E M Bonnem - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

E M Bonnem

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989

Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effectsJ A Thompson, D J Lee, P Kidd, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1987

Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effectsJ A Thompson, W W Cox, C G Lindgren, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987

A phase I clinical trial of recombinant DNA gamma interferonT D Brown, J Koeller, K Beougher, et al.

Seminars in Oncology|June 1, 1987

Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemiaH M Golomb, A Fefer, D W Golde, et al.

Annals of Internal Medicine|February 1, 1992

Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphomaR Advani, N J Chao, S J Horning, et al.

Leukemia & Lymphoma|July 28, 2016

Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 PatientsH M Golomb, M J Ratain, A Fefer, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989

Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effectsJ A Thompson, D J Lee, P Kidd, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1987

Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effectsJ A Thompson, W W Cox, C G Lindgren, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987

A phase I clinical trial of recombinant DNA gamma interferonT D Brown, J Koeller, K Beougher, et al.

Seminars in Oncology|June 1, 1987

Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemiaH M Golomb, A Fefer, D W Golde, et al.

Annals of Internal Medicine|February 1, 1992

Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphomaR Advani, N J Chao, S J Horning, et al.

Leukemia & Lymphoma|July 28, 2016

Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 PatientsH M Golomb, M J Ratain, A Fefer, et al.

Pageof 2